Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L).

Progressive Motor Deficit is Mediated by the Denervation of Neuromuscular Junctions and Axonal Degeneration in Transgenic Mice Expressing Mutant (P301S) Tau Protein.

Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice.

Review Tau phosphorylation and aggregation as a therapeutic target in tauopathies.

Review Biochemical isolation of insoluble tau in transgenic mouse models of tauopathies.

NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy.

Active zone proteins are transported via distinct mechanisms regulated by Par-1 kinase.

Review Physiological and pathophysiological functions of Swiprosin-1/EFhd2 in the nervous system.